The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not sep ...
Destiny Pharma PLC 11 June 2024 Destiny Pharma plc ("Destiny Pharma" or "the Company") Destiny Pharma Awarded Innovation Passport...
Destiny Pharma PLC 24 May 2024 Destiny Pharma plc ("Destiny Pharma" or the "Company") Exercise of Options and Total Voting Rights ...
Destiny Pharma PLC 09 May 2024 Destiny Pharma plc ("Destiny Pharma" or "the Company") Posting of Annual Report and Accounts, and Notice of...
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...
Destiny Pharma PLC 25 April 2024 25 April 2024 Destiny Pharma plc ("Destiny Pharma" or "the company") Audited results for the year ended...
Destiny Pharma PLC 08 April 2024 08 April 2024 Destiny Pharma plc ("Destiny Pharma" or "the Company") Notice of Full Year Results and...
Destiny Pharma PLC 19 March 2024 Destiny Pharma plc ("Destiny Pharma" or the "Company") Exercise of Options and Total Voting Rights ...
The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not s ...
Destiny Pharma PLC 31 January 2024 Destiny Pharma plc ("Destiny Pharma" or "the Company") Clinical development update Positive Results...
Destiny Pharma PLC 22 January 2024 Destiny Pharma plc ("Destiny Pharma" or "the Company") Appointment of Nominated Adviser and...
Destiny Pharma PLC on Thursday said that its priority remains promoting its XF-73 Nasal antibacterial drug. The Brig ...
Destiny Pharma PLC 04 January 2024 Destiny Pharma plc ("Destiny Pharma" or "the Company") Year End Business Update Brighton...
Destiny Pharma PLC's XF-73 is "the real deal", said Equity Development on Friday, after the biotechnology company on ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads